REGULATION FOR DEVELOPMENT OF BIOSIMILAR : A REVIEW

Abstract

Present article signifies the exigency for regulation and regulatory bodies involved in development of biosimilars. The principle for development of biosimilars included opting adequate reference product, manufacturing process optimisation, quality control procedure, preclinical and clinical studies. India’s first guidelines were enforced in 2012, with amendments in 2016. Thus, we elaborated the amended guidelines for development of biosimilars. Keywords: Biosimilars; Manufacturing; Stability; Efficacy; India Guidelines.

Authors and Affiliations

Chauhan K Meenakshi| NDDS Research Lab, Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gupta S K| Clinical Research Department, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gupta Surbhi| Clinical Research Department, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gulati Anshu| NDDS Research Lab, Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017

Keywords

Related Articles

SAFETY ASSESSMENT OF DIABECON: AN AYURVEDIC FORMULATION IN RATS

Diabecon an ayurvedic formulation was tested for safety by estimation of heavy metal contents and also for acute and sub chronic toxicity. Heavy metal content in formulation were tested and found to be within limit as p...

IMPORTANCE OF ROLE OF PHARMACIST MEDIATED ADHERENCE IN HYPERTENSIVE PATIENTS A BRIEF OVERVIEW

Hypertension is an important risk factor for cardiovascular disease, the incidence of which it is possible to reduce by prophylactic treatment with antihypertensive drugs. Adherence to long-term therapies for chronic di...

ELECTRONIC TRIAL MASTER FILE (eTMF) - AN INDISPENSABLE TOOL THAT COLLECTS AND FILES ESSENTIAL DOCUMENTS OF A CLINICAL TRIAL: A REVIEW

Every organization involved in clinical trials in the BioPharma industry maintains a trial master file comprised of thousands of pages of regulatory documents required for each clinical trial. Managing thousands of clin...

AN OVERVIEW ON MICROWAVE MEDIATED SYNTHESIS

Microwave-assisted organic synthesis is an enabling technology for accelerating drug discovery and development processes. Microwave organic synthesis opens up new opportunities to the synthetic chemist in the form of ne...

THE EFFECT OF CONSUMPTION OF DIFFERENT FOODS ON BODY MASS INDEX OF OVERWEIGHT WOMEN

Food pattern is one of factors influencing on incidence of chronic diseases such as colon cancer, hypertension, and vascular diseases. World health organization states that increase of obesity throughout the world threa...

Download PDF file
  • EP ID EP15984
  • DOI -
  • Views 505
  • Downloads 144

How To Cite

Chauhan K Meenakshi, Gupta S K, Gupta Surbhi, Gulati Anshu (2016). REGULATION FOR DEVELOPMENT OF BIOSIMILAR : A REVIEW. International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 5(6), 2362-2368. https://europub.co.uk/articles/-A-15984